Providers Clinical Support System – Substance Use Disorder Treatment (PCSS-SUD Treatment)
Description
The purpose of this program is to provide training and technical assistance, mentoring, and ongoing support for healthcare professionals in general health and behavioral health settings to increase their capacity to identify and treat substance use disorders, especially opioid and alcohol use disorders.
Award Ceiling
$3.0M
Total Funding
$3.0M
CFDA Number
93.490
Funding Instrument
Cooperative Agreement
Funding Level
Federal
Jurisdiction
US
Cost Sharing
No
Open Date
May 15, 2026
Close Date
June 15, 2026
Posted Date
May 15, 2026
Eligible Applicant Types
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Tags
HHS-SAMHS-SAMHSACFDA:93.490Cooperative AgreementHealth
Related Health & Human Services Grants
NIH Brain Development Cohorts (NBDC) Biospecimen Access (X01 Clinical Trial Not Allowed)
National Institutes of Health
0d left
Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required)
National Institutes of Health
0d left
HIV Prevention and Alcohol (R01 Clinical Trials Optional)
National Institutes of Health
0d left
Limited Competition: Small Grant Program for ORIP Special Emphasis Research Career Award (SERCA) K01 Recipients (R03 Clinical Trial Not Allowed)
National Institutes of Health
0d left